title: Effect of 2-week treatment with pirenzepine on fasting and postprandial glucose concentrations in individuals with type 2 diabetes.
authors.forename: Basil G
authors.initials: BG
authors.lastname: Issa
authors.forename: Nichola
authors.initials: N
authors.lastname: Davies
authors.forename: Kerenza
authors.initials: K
authors.lastname: Hood
authors.forename: Lakdasa D K E
authors.initials: LD
authors.lastname: Premawardhana
authors.forename: John R
authors.initials: JR
authors.lastname: Peters
authors.forename: Maurice F
authors.initials: MF
authors.lastname: Scanlon
mesh_terms: D001786:Blood Glucose / Q000378:metabolism*; D018592:Cross-Over Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D004311:Double-Blind Method; D005215:Fasting / Q000502:physiology*; D006801:Humans; D007328:Insulin / Q000097:blood; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D010890:Pirenzepine / Q000627:therapeutic use*
chemical_list: D001786:Blood Glucose; D007328:Insulin; D018727:Muscarinic Antagonists; D010890:Pirenzepine